Obsidian Therapeutics

Obsidian Therapeutics

Obsidian Therapeutics

Obsidian Therapeutics, founded in 2015, aspires to extend adoptive immunotherapy to every patient with cancer.
Founded
2015
Raised
$49.5M
Follow us
Alexa global traffic share
Latest funding
$49,500,000
Venture capital (Series A) - 2017
Atlas Venture GV Amgen Ventures +4
Team Size
10+
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Obsidian Therapeutics makes some noise.